Skip to content
Search

Latest Stories

Self-care with OTC medicines could save NHS £1.7bn annually, says PAGB report

Self-care with OTC medicines could save NHS £1.7bn annually, says PAGB report

PAGB emphasises the need to agree on a long-term funding settlement for community pharmacy to ensure patient access to and advice on OTC medicines

A PAGB report has emphasised the need to empower the public to practice self-care and improve access to over-the-counter (OTC) medicines to alleviate pressure on GPs and reduce NHS costs.

Launched at the Labour Party Conference today, the PAGB’s State of the Nation report explores the current state of self-care and OTC medicines.


The report outlines 11 recommendations for the government to consider as part of its strategy to build an NHS fit for the future.

It highlights that each year, at least 25 million GP appointments and 5 million A&E visits are used for self-treatable illnesses, which can be effectively managed through self-care.

The report suggests that empowering individuals to utilise OTC medicines could save the NHS at least £1.7 billion per year in costs.

Furthermore, it says that eliminating these appointments could save the economy an additional £350m per year, as employees would not need to take time off work for unnecessary treatments.

PAGB welcomed the government’s manifesto commitments to take pressure off GP surgeries by “improving access to services and treatment through new routes” and to expand the role of pharmacists.

The association also expressed approval for the recognition of self-care and pharmacy in the recent report from Lord Darzi’s investigation of NHS England.

“As the new Government reflects on the review and sets out its plans to deliver on these commitments and fix the “broken” NHS – including through the development of the 10-year plan – it is vital that policies to widen access to OTC medicines and empower people to self-care are prioritised,” it said.

PAGB acknowledged that there has been a notable shift in policy towards enhancing the role of pharmacy, expanding access to OTC medicines and encouraging self-care, but  noted “there is still work to be done.”

The association stressed the need to maintain this momentum and ensure people are empowered and supported to access “the right care, in the right place and at the right time.”

The report calls on the government to launch a dedicated self-care ‘hub’ on the NHS App and website - utilising support from industry.

It also recommends that the government support the recent proposal to include self-care for minor ailments and the role of pharmacists as knowledgeable healthcare professionals in the relationships, sex, and health education curriculum by the end of secondary school.

Additionally, it urges the government to collaborate with the Reclassification Alliance to explore opportunities for expanding the use of 25 OTC products over the next five years.

PAGB also emphasised the need to agree on a long-term funding settlement for community pharmacy that reflects its role in supporting NHS delivery and ensures patient access to and advice on OTC medicines.

PAGB’s recommendations for the government to action also include:

  • Re-evaluating the restrictive criteria for switching a POM to OTC to allow timely access to effective treatments (e.g. injectables to treat life-threatening allergic reactions)
  • Implement policies to incentivise the OTC sector to reclassify their products in the UK
  • Fostering open and collaborative relationships with industry, ensuring the UK remains an attractive hub for OTC innovation
  • Including OTC products in innovative schemes to encourage access to medicine
  • Optimising grant and funding opportunities for small and medium OTC sector businesses

The association noted that the report has been developed to support the government in shaping policy around self-care and access to OTC medicines.

 

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less